From Pharmacy to the Frontlines of Brain and Cancer Research: A GlobalScientist’s Pursuit of Better Medicine

Adenike Oyegbesan’s path from pharmacist in Nigeria to PhD researcher in the United States is the kind of story that brings science closer to home. Rooted in both patient care and laboratory innovation, her work is part of a growing movement to close the gap between academic discovery and clinical impact.

“My journey began in clinical practice,” she shares. “I was a pharmacist engaging with patients, seeing the limits of treatment options firsthand. That was where I began to ask: what can we do better?” This curiosity and compassion drove her to leave her home country and pursue advanced research in pharmaceutical sciences in the U.S.

Currently a third-year PhD student in California, Oyegbesan’s work has evolved across two major therapeutic frontiers: cancer and neurodegenerative disease. Her early training was in a lab developing targeted lipid nanoparticles to treat resistant pancreatic cancer one of the deadliest and most stubborn forms of the disease. “We used what’s called a molecular Trojan horse approach,” she explains, “to sneak therapies into tumor cells and bypass resistance mechanisms.”

Her passion for translational research led her next to the blood-brain barrier (BBB), one of the greatest challenges in treating neurological conditions. “So many drugs don’t make it to the brain because of this barrier,” she says. Now focused on Alzheimer’s disease, Oyegbesan works on transferrin receptor antibody fusion proteins specialized molecules designed to cross the BBB and deliver therapeutic payloads. “We’re studying how these fusion proteins behave over time in the body, especially during chronic dosing, because that’s what patients will experience. Understanding the pharmacokinetics is essential if we want our work to make it into real-world clinical settings.”

Her work, she says, is about more than molecules. It’s about making sure scientific breakthroughs can become medicines. “I’ve always been interested in the journey from bench to bedside. That’s the bridge I’m building.”

It’s a bridge strengthened by her background in pharmacy and recognized academic excellence. Oyegbesan is a member of Rho Chi, the international honor society for pharmaceutical sciences, and has received multiple awards for academic distinction from the Pharmaceutical Society of Nigeria to the Dean’s List at Western University of Health Sciences.

Her research spans immunology, drug delivery, and neuropharmacology but it’s her translational mindset that sets her apart. “Science is only as good as its ability to reach people,” she reflects. “I see myself using my knowledge base deeply cross-disciplinary to solve practical problems in the pharmaceutical industry in the future.”

In an age when health challenges are becoming more complex, researchers like Adenike Oyegbesan remind us that solutions aren’t found in silos. They are found in the minds of those who understand both the patient and the pipeline. From Nigeria to California, from pharmacy to drug delivery, she is building the next generation of drugs one innovation at a time.